Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
about
Spread of artemisinin resistance in Plasmodium falciparum malariaMalaria in the Greater Mekong Subregion: heterogeneity and complexityPfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaOccurrence of pfatpase6 Single Nucleotide Polymorphisms Associated with Artemisinin Resistance among Field Isolates of Plasmodium falciparum in North-Eastern TanzaniaArtemisinin Resistance in Plasmodium falciparum MalariaMolecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug ProductionArtemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient dataMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsFocused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, CambodiaPast and new challenges for malaria control and elimination: the role of operational research for innovation in designing interventionsStatus of potential PfATP6 molecular markers for artemisinin resistance in SurinamePlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Treatment with coartem (artemether-lumefantrine) in Papua New GuineaHigh heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia.Laboratory detection of artemisinin-resistant Plasmodium falciparumDecreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments.Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.Emerging artemisinin resistance in the border areas of Thailand.Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions.Artemisinin Antimalarials: Preserving the "Magic Bullet"Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.Drug-Resistant Malaria: The Era of ACT.In vivo parasitological measures of artemisinin susceptibilityDiscovery, mechanisms of action and combination therapy of artemisininOrally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover studyArtemether-lumefantrine compared to atovaquone-proguanil as a treatment for uncomplicated Plasmodium falciparum malaria in travelers.A small amount of fat does not affect piperaquine exposure in patients with malaria.Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border areaMass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquineMonitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children.Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.Efficacy of artemether-lumefantrine in area of high malaria endemicity in India and its correlation with blood concentration of lumefantrine.Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
P2860
Q21032481-2BF067C1-668A-4BAF-9873-8AF11F1A4F39Q21032492-D3ABA259-206F-40E3-82E4-12540270DC4AQ21034146-F5CB1880-ACB7-40D0-AF34-7F66215C23A1Q21284494-4908AD73-4E8E-4438-BB02-DDA11D32F47FQ22061852-587366FE-5CF9-4A76-87AB-C7A1828EDF9DQ26752273-6618EB45-7A66-46FA-952B-655D40DAA7A9Q26783646-B6CD0075-BFD1-4DF1-9B9C-412D26E08DD2Q27000750-2B22CB9F-41A4-4AD1-9CBD-CAE105ECC64BQ28484164-28514391-BD18-4FAB-8B39-BFB9466C8B34Q28646971-F0C7DC84-0262-4CE9-B116-1AD4837CC9F5Q29353788-07CB81E9-7518-4017-9D68-F22DB3E00D68Q30240158-CA5FBF48-B27C-4EA8-8BA5-497BBED1E131Q30379780-532811D6-FE1D-44D7-9865-70303EF451C9Q30483555-69E69C65-5514-4912-B0CC-128A07B0A1BCQ33559051-FB4F3D8D-3933-46FD-9DA0-4BA3DBC1E4ECQ33655603-08DE7EF4-E038-4344-99A6-2D8A074ABFF5Q33749688-7EE89A77-2EE5-4FDE-9628-D3EEE7736CDEQ33785789-50712A9A-E2DB-4838-99D8-0D87E2EA005BQ33798139-1DCD5B84-EB05-4F5B-BCC0-F8627A370D0AQ33826378-922F61F3-4352-4D96-A91F-F1622EC1E5D8Q33841526-B605E30A-7D39-4909-8725-F2A7D6FAC79CQ34058351-A65DF33E-15E1-4130-98D1-9FAFE6ED5852Q34343530-734660E4-AFDD-47A6-8B33-81548034A3B5Q34488950-0FB2D46A-99C4-4686-9967-75E7AAE6CEE6Q34622342-E9016E49-A832-4F1D-9B33-4344EA52664DQ34677891-F71AB01F-815A-4193-BC0A-F6F4024754C3Q34681141-DE799145-159F-4A97-8FB5-1078C1BEB8E9Q34921155-46C9E5A1-2C07-49C4-AEC7-8C03568A07BEQ35006418-9D3CB7DD-065B-40C3-84FD-93FAE0F86DFAQ35056250-66839C38-E486-4809-8FB1-A10570FD4FFAQ35140545-B539FD2F-0748-47A9-83CF-A690CE72AD9DQ35191426-F78429B7-93E6-485A-BD87-51289C62A4B3Q35203883-8A8C5EF9-AC26-4448-8245-343A55ED445AQ35224221-160F4DCA-7329-4AD7-9A5B-9A41B5FEE310Q35385674-ADDD8C83-5AAF-43C0-A354-3551DF50DD53Q35538818-EED946F4-A18A-49CA-8C2B-490443CF377BQ35598594-862A3CA5-5F18-47B7-AAFB-8444925DA584Q35771768-3EDB3ACC-D0F2-4B03-AE41-72DEDB9FA62AQ35834996-FBC3A461-69A0-4C14-BC9D-DF8766416F62Q35859839-1A0A1280-0833-462E-B4E3-3908EA00BEC3
P2860
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Efficacy of artemether-lumefan ...... malaria in northwest Cambodia.
@en
Efficacy of artemether-lumefan ...... malaria in northwest Cambodia.
@nl
type
label
Efficacy of artemether-lumefan ...... malaria in northwest Cambodia.
@en
Efficacy of artemether-lumefan ...... malaria in northwest Cambodia.
@nl
prefLabel
Efficacy of artemether-lumefan ...... malaria in northwest Cambodia.
@en
Efficacy of artemether-lumefan ...... malaria in northwest Cambodia.
@nl
P2093
P2860
P921
P1476
Efficacy of artemether-lumefan ...... malaria in northwest Cambodia.
@en
P2093
Anna Annerberg
Duong Socheat
Eva Maria Christophel
Mey Bouth Denis
Niklas Lindegardh
Pascal Ringwald
Poravuth Yi
Reiko Tsuyuoka
Sophoan Narann Top
Thierry Fandeur
P2860
P304
P356
10.1111/J.1365-3156.2006.01739.X
P50
P577
2006-12-01T00:00:00Z